Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats
Year: 2008
Type: article
Abstract: Bitter melon (Momordica charantia; BM) has been shown to ameliorate diet-induced obesity and insulin resistance. To examine the effect of BM supplementation on cell size and lipid metabolism in adipose tissues, three groups of rats were respectively fed a high-fat diet supplemented without (HF group) or with 5 % lyophilised BM powder (HFB group), or with 0.01 % thiazolidinedione (TZD) (HFT group). A group of rats fed a low-fat diet was also included as a normal control. Hyperinsulinaemia and glucose intolerance were observed in the HF group but not in HFT and HFB groups. Although the number of large adipocytes (>180 microm) of both the HFB and HFT groups was significantly lower than that of the HF group, the adipose tissue mass, TAG content and glycerol-3-phosphate dehydrogenase activity of the HFB group were significantly lower than those of the HFT group, implying that BM might reduce lipogenesis in adipose tissue. Experiment 2 was then conducted to examine the expression of lipogenic genes in adipose tissues of rats fed low-fat, HF or HFB diets. The HFB group showed significantly lower mRNA levels of fatty acid synthase, acetyl-CoA carboxylase-1, lipoprotein lipase and adipocyte fatty acid-binding protein than the HF group (P < 0.05). These results indicate BM can reduce insulin resistance as effective as the anti-diabetic drug TZD. Furthermore, BM can suppress the visceral fat accumulation and inhibit adipocyte hypertrophy, which may be associated with markedly down regulated expressions of lipogenic genes in the adipose.
Source: British Journal Of Nutrition
Authors: Hui-Ling Huang, Ya-Wen Hong, You-Hong Wong, Ying-Nien Chen, Jong-Ho Chyuan, Ching-Jang Huang, Pei-Min Chao
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: Momordica charantia, diet-induced obesity, adipocyte hypertrophy, lipogenesis, lipogenic gene expression, insulin resistance, high-fat diet, thiazolidinediones, fatty acid synthase, acetyl-CoA carboxylase 1, lipoprotein lipase, adipocyte fatty acid-binding protein, visceral fat accumulation, impaired glucose tolerance, hyperinsulinemia, glycerol-3-phosphate dehydrogenase, lipid metabolism
Open Access status: bronze
OpenAlex ID: W2112035969
